| |
| Magyar Immunológiai Társaság |
|
| Prof. Dr. Radványi László előadása (Budapest, 2011. 04.29.) |
 Rendezvény kezdete: 2011.04.29. | Rendezvény vége: 2011.04.29. |
| Helyszín: 1122 Budapest, Ráth Gy. u. 7-9., Országos Onkológiai Intézet, 1. épület / I. emelet/ Főigazgatói tanácsterem |
Helyszín: Országos Onkológiai Intézet, 1. épület / I. emelet/ Főigazgatói tanácsterem
1122 Budapest, Ráth Gy. u. 7–9.
Időpont: 2011. április 29. péntek d.u. 13h
Az Országos Onkológiai Intézet tumorimmunológiai – és melanoma kutatási munkái kapcsán meghívott vendégünk:
Prof. Dr. Laszlo G. Radvanyi
Associate Professor Department of Melanoma and Breast Medical Oncology
University of Texas, M.D. ANDERSON CANCER CENTER
Houston, TX 77030, USA
előadásának címe:
UNLEASHING THE POWER OF
THE IMMUNE SYSTEM AGAINST METASTATIC MELANOMA
Minden érdeklődőt tisztelettel és szeretettel (kávéval és süteménnyel) várunk!
Kotlán Beatrix / Molekuláris Immunológiai és Toxikológiai Osztály, Országos Onkológiai Intézet, Budapest
E.mail: kotlanb@netscape.net
Tel: (06 1) 224 8600/ 3294 v. 2239 mellék |
|
|
 |
| |
| Magyar Nephrologiai Társaság |
|
| 44th Course on Advances in Nephrology, Dialysis, and Transplantation |
| Rendezvény kezdete: 2012.12.06. | Rendezvény vége: 2012.12.09. |
| Helyszín: Olaszország, Milánó, Milan Marriott Hotel |
Lessons are given by the best international experts and the Course is attended by more than one thousand participants (nephrologists, cardiologists and internists).
More than 20 companies of the pharmaceutical, laboratory, instrumentation, and scientific publishing field are involved each year as sponsors and several of them organize satellite meetings during the intervals between lessons or on the starting day of the Course.
A simultaneous translation (Italian-English and vice-versa) is operative during the whole course, allowing the active attendance not only of Italian, but also of foreign participants.
This year we are organizing the 44th Edition of the Course that will be held at the Milan Marriott Hotel (www.marriott.com/hotels/travel/milit-milan-marriott-hotel/, via Washington 66), on December 6-9, 2012.
|
|
Kapcsolódó dokumentumok (2)
|
|
| |
| Magyar Pszichiátriai Társaság |
|
| World Psychiatric Association Thematic Conference on Intersectional Collaboration: “The Multidisciplinary Facets of Psychiatry” |
| Rendezvény kezdete: 2012.11.29. | Rendezvény vége: 2012.12.02. |
| Szakterület(ek): Pszichiátria, mentálhigiéné |
| Helyszín: Greece, Athens, |
| A rendezvény Web oldala: http://www.psych-relatedsciences.org |
World Psychiatric Association Thematic Conference on Intersectional
Collaboration: “The Multidisciplinary Facets of Psychiatry” The First Athens Congress on 'Psychiatry and Related Sciences' 4th European Congress of the International Neuropsychiatric Association
Organizer: Hellenic Society for the Advancement of Psychiatry and Related Sciences
Collaboration:
1) International Neuropsychiatric Association
2) World Federation of Society of Biological Psychiatry
Contact: Prof. Constantin R. Soldatos / Ms. Penelopi Mitroyanni
Email: info@psych-relatedsciences.org |
|
|
|
| |
| Magyar Dermatológiai Társulat |
|
| Upgrading Course on Aesthetic Medicine |
| Rendezvény kezdete: 2012.11.29. | Rendezvény vége: 2012.11.30. |
| Szervező: Dror Alon |
| E-mail: dror@omni-present.co.il |
| Helyszín: Izrael, Tel Aviv, |
Dr. Monica Elman, a well-known dermatologist, laser and IPL specialist in Israel will conduct a unique international Aesthetic Course that will be held in Israel on November 29-30, 2012.
The course targets physicians interested in enhancing their practical skills in Aesthetic Medicine.
During the course participants will be practicing innovative Aesthetic procedures with "hands on" human cadavers, and, in part, on live candidates.
The course will be conducted by Dr. M. Elman together with international specialists in the field.
Dr. M. Elman is the coauthor of the Dermatology book "Aesthetic Applications of Intense Pulsed Light", studied in USA medical schools. Her Aesthetic state of the art offices were chosen by the FDA regulatory offices to serve as a control |
|
|
|
